Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study

BACKGROUND: The prevalence of adult chronic kidney disease and cardiovascular comorbidities in Canadian Indigenous communities is largely unknown. We conducted a study to document the prevalence of chronic kidney disease and concurrent diabetes mellitus, hypertension and dyslipidemia in a First Nati...

Full description

Bibliographic Details
Published in:CMAJ Open
Main Authors: Kelly, Len, Matsumoto, Cai-lei, Schreiber, Yoko, Gordon, Janet, Willms, Hannah, Olivier, Christopher, Madden, Sharen, Hopko, Josh, Tobe, Sheldon W.
Format: Text
Language:English
Published: Joule Inc. or its licensors 2019
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768774/
http://www.ncbi.nlm.nih.gov/pubmed/31501170
https://doi.org/10.9778/cmajo.20190040
id ftpubmed:oai:pubmedcentral.nih.gov:6768774
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:6768774 2023-05-15T16:15:23+02:00 Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study Kelly, Len Matsumoto, Cai-lei Schreiber, Yoko Gordon, Janet Willms, Hannah Olivier, Christopher Madden, Sharen Hopko, Josh Tobe, Sheldon W. 2019-09-06 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768774/ http://www.ncbi.nlm.nih.gov/pubmed/31501170 https://doi.org/10.9778/cmajo.20190040 en eng Joule Inc. or its licensors http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768774/ http://www.ncbi.nlm.nih.gov/pubmed/31501170 http://dx.doi.org/10.9778/cmajo.20190040 Copyright 2019, Joule Inc. or its licensors Research Text 2019 ftpubmed https://doi.org/10.9778/cmajo.20190040 2019-10-27T00:14:34Z BACKGROUND: The prevalence of adult chronic kidney disease and cardiovascular comorbidities in Canadian Indigenous communities is largely unknown. We conducted a study to document the prevalence of chronic kidney disease and concurrent diabetes mellitus, hypertension and dyslipidemia in a First Nations population in northwest Ontario. METHODS: In this observational study, we used retrospective data collected from regional electronic medical records of 16 170 adults (age ≥ 18 yr) from 26 First Nations communities in northwest Ontario from May 2014 to May 2017. Demographic and laboratory data included age, gender, prescribed medications, estimated glomerular filtration rate, urine albumin:creatinine ratio, low-density lipoprotein cholesterol (LDL-C) level and glycated hemoglobin (HbA(1c)) concentration. We identified patients with diabetes by an HbA(1c) concentration of 6.5% or higher, or the use of a diabetic medication, those with dyslipidemia by an elevated LDL-C level (≥ 2.0 mmol/L) or use of lipid-lowering medication, and those with hypertension by use of antihypertensive medication. RESULTS: Of the 16 170 adults residing in the communities, 5224 unique patients (32.3%) had renal testing (albumin:creatinine ratio and/or estimated glomerular filtration rate). The age-adjusted prevalence of chronic kidney disease was 14.5%, and the prevalence of stage 3–5 chronic kidney disease (estimated glomerular filtration rate < 60 mL/min) was 7.0%. Most patients with chronic kidney disease (1487 [80.0%]) had at least 1 cardiovascular comorbidity. A total of 1332 patients (71.6%) had diabetes, 1313 (70.6%) had dyslipidemia, and 1098 (59.1%) had hypertension; all 3 comorbidities were present in 716 patients (38.5%). INTERPRETATION: We document a high prevalence of advanced chronic kidney disease in this First Nations population, 7.0%, double the rate in the general population. High rates of cardiovascular comorbidities were also common in these patients with chronic kidney disease, which places them at increased risk for ... Text First Nations PubMed Central (PMC) CMAJ Open 7 3 E568 E572
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Research
spellingShingle Research
Kelly, Len
Matsumoto, Cai-lei
Schreiber, Yoko
Gordon, Janet
Willms, Hannah
Olivier, Christopher
Madden, Sharen
Hopko, Josh
Tobe, Sheldon W.
Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study
topic_facet Research
description BACKGROUND: The prevalence of adult chronic kidney disease and cardiovascular comorbidities in Canadian Indigenous communities is largely unknown. We conducted a study to document the prevalence of chronic kidney disease and concurrent diabetes mellitus, hypertension and dyslipidemia in a First Nations population in northwest Ontario. METHODS: In this observational study, we used retrospective data collected from regional electronic medical records of 16 170 adults (age ≥ 18 yr) from 26 First Nations communities in northwest Ontario from May 2014 to May 2017. Demographic and laboratory data included age, gender, prescribed medications, estimated glomerular filtration rate, urine albumin:creatinine ratio, low-density lipoprotein cholesterol (LDL-C) level and glycated hemoglobin (HbA(1c)) concentration. We identified patients with diabetes by an HbA(1c) concentration of 6.5% or higher, or the use of a diabetic medication, those with dyslipidemia by an elevated LDL-C level (≥ 2.0 mmol/L) or use of lipid-lowering medication, and those with hypertension by use of antihypertensive medication. RESULTS: Of the 16 170 adults residing in the communities, 5224 unique patients (32.3%) had renal testing (albumin:creatinine ratio and/or estimated glomerular filtration rate). The age-adjusted prevalence of chronic kidney disease was 14.5%, and the prevalence of stage 3–5 chronic kidney disease (estimated glomerular filtration rate < 60 mL/min) was 7.0%. Most patients with chronic kidney disease (1487 [80.0%]) had at least 1 cardiovascular comorbidity. A total of 1332 patients (71.6%) had diabetes, 1313 (70.6%) had dyslipidemia, and 1098 (59.1%) had hypertension; all 3 comorbidities were present in 716 patients (38.5%). INTERPRETATION: We document a high prevalence of advanced chronic kidney disease in this First Nations population, 7.0%, double the rate in the general population. High rates of cardiovascular comorbidities were also common in these patients with chronic kidney disease, which places them at increased risk for ...
format Text
author Kelly, Len
Matsumoto, Cai-lei
Schreiber, Yoko
Gordon, Janet
Willms, Hannah
Olivier, Christopher
Madden, Sharen
Hopko, Josh
Tobe, Sheldon W.
author_facet Kelly, Len
Matsumoto, Cai-lei
Schreiber, Yoko
Gordon, Janet
Willms, Hannah
Olivier, Christopher
Madden, Sharen
Hopko, Josh
Tobe, Sheldon W.
author_sort Kelly, Len
title Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study
title_short Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study
title_full Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study
title_fullStr Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study
title_full_unstemmed Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study
title_sort prevalence of chronic kidney disease and cardiovascular comorbidities in adults in first nations communities in northwest ontario: a retrospective observational study
publisher Joule Inc. or its licensors
publishDate 2019
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768774/
http://www.ncbi.nlm.nih.gov/pubmed/31501170
https://doi.org/10.9778/cmajo.20190040
genre First Nations
genre_facet First Nations
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768774/
http://www.ncbi.nlm.nih.gov/pubmed/31501170
http://dx.doi.org/10.9778/cmajo.20190040
op_rights Copyright 2019, Joule Inc. or its licensors
op_doi https://doi.org/10.9778/cmajo.20190040
container_title CMAJ Open
container_volume 7
container_issue 3
container_start_page E568
op_container_end_page E572
_version_ 1766001126026510336